Business Unit Director
BeOne
Business Unit Director
BeOne
Global oncology therapeutics discovery, development, manufacturing
BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.
The Business Unit Director, Solid Tumors will lead the commercial strategy and execution for BeOne's Solid Tumor portfolio in Israel, with end-to-end commercial responsibility from pre-launch and launch through growth and lifecycle management.
The role will lead the Solid Tumor commercial team and work closely with Medical, Market Access and other cross-functional partners to maximize patient access, drive business performance and successfully establish BeOne's Solid Tumor portfolio in Israel.
Essential Functions of the job:
Responsibilities include, but are not necessarily limited to, the following:
Qualifications:
Supervisory Responsibilities:
The incumbent will lead, coach and develop the Solid Tumor sales and marketing team and will have people-leadership responsibility for the commercial organization within the business unit.
Travel: Ability to travel
Global Competencies
When we exhibit our values of Patients First, Driving Excellence, Bold Ingenuity, and Collaborative Spirit, through our twelve global competencies below, we help get more affordable medicines to more patients around the world.
We are proud to be an equal opportunity employer. BeOne does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, disability, national origin, veteran status or any other basis covered by appropriate law. All employment is decided on the basis of qualifications, merit, and business need.
BeOne Medicines discovers, develops, and commercializes oncology therapies worldwide, focusing on hematologic cancers and solid tumors. Its products work by leveraging internal R&D and clinical development to bring therapies to market quickly, with Brukinsa serving as a leading backbone in the US and European markets. It differentiates itself through a large-scale global clinical network and cost-efficient development and manufacturing that support high margins and a focus on large-market cancer indications. Its goal is to expand access to high-impact, affordable cancer treatments across more than 45 countries while growing its pipeline into immunology and solid tumors.
Explore more opportunities at BeOne